Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725101 · ClinicalTrials.gov registry record
Fibromyalgia Health Outcome Study on Cost of Treatments
A clinical trial, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 1,700
- Enrollment target
NCT00725101: Completed study, sponsored by Eli Lilly and Company.
NCT00725101 is a clinical trial that has completed, run by Eli Lilly and Company. The registered enrollment target is 1,700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00725101 has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 1,700 participants
- Enrollment target
Study Summary
The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patterns and health outcomes of adult participants diagnosed by their physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent" for FM. The primary benefit of this study is enhanced understanding of the disease state of FM and the role that pharmacologic treatment plays, which may help to optimize management of FM. This study will address current gaps in a rapidly growing body of literature on FM.
Interventions
- DRUG Treatment for Fibromyalgia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-04 |
What the finished NCT00725101 record still lists
NCT00725101 is an observational study that tracks outcomes without assigning an intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Treatment for Fibromyalgia is the first listed.
NCT00725101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00725101 about?
NCT00725101 is a clinical study titled "Fibromyalgia Health Outcome Study on Cost of Treatments". The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patter...
What is the current status of trial NCT00725101?
This trial is currently completed. The enrollment target is 1,700 participants. The study started on 2008-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00725101?
The interventions under investigation include: Treatment for Fibromyalgia (DRUG).
Who is sponsoring clinical trial NCT00725101?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia